Breaking News Instant updates and real-time market news.

EIGR

Eiger BioPharmaceuticals

$10.25

0.05 (0.49%)

16:35
10/15/18
10/15
16:35
10/15/18
16:35

683 Capital reports 5.9% passive stake in Eiger BioPharmaceuticals

  • 27

    Nov

EIGR Eiger BioPharmaceuticals
$10.25

0.05 (0.49%)

05/18/18
PIPR
05/18/18
NO CHANGE
Target $28
PIPR
Overweight
Eiger BioPharmaceuticals price target raised to $28 from $17 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Eiger BioPharmaceuticals (EIGR) to $28 after the company expanded its lonafarnib licensing agreement with Merck (MRK) for rights in ultra-orphan indication Hutchinson-Gilford Progeria syndrome. The analyst now anticipates FDA approval of lonafarnib in HGPS in 2020. He reiterates an Overweight rating on Eiger shares.
05/30/18
PIPR
05/30/18
NO CHANGE
Target $24
PIPR
Overweight
Eiger BioPharmaceuticals price target lowered to $24 from $28 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Eiger BioPharmaceuticals to $24 to account for dilution from the recent financing. The analyst expects Phase II readouts for exendin in hypoglycemia and ubenimex in lymphedema in Q3. He reiterates an Overweight rating on the shares.
08/27/18
JEFF
08/27/18
NO CHANGE
Target $25
JEFF
Buy
Jefferies sees good entry point for Eiger BioPharmaceuticals ahead of update
Jefferies analyst Maury Raycroft believes current Eiger BioPharmaceuticals share levels offer a good entry point ahead of news from the Phase III D-LIVR endpoints in hepatitis delta virus based on FDA feedback. The analyst does not anticipate major surprises around the update and expect the outcome to be viewed positively. The announcement should give the stock a bump and add momentum to a second half of 2018 run-up that will include several key catalysts, Raycroft tells investors in a research note. He sees little downside risk in Eiger shares and keeps a Buy rating on the name with a $25 price target.
09/04/18
PIPR
09/04/18
NO CHANGE
Target $24
PIPR
Overweight
Eiger can file lonafarnib without additional studies, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says feedback from the FDA will enable Eiger BioPharmaceuticals to file an investigational new drug application for lonafarnib to treat orphan indication Hutchinson-Gilford Progeria syndrome as soon as 2019. Importantly, this accelerates anticipated timelines because Eiger is not required to conduct additional clinical studies for approval, Tenthoff tells investors in a research note. He beieves that if approved, Eiger "could gain a valuable Pediatric Priority Review Voucher shared with the Progeria Research Foundation." The analyst reiterates an Overweight rating on the shares with a $24 price target.

TODAY'S FREE FLY STORIES

RLGY

Realogy

$11.82

0.02 (0.17%)

13:45
03/25/19
03/25
13:45
03/25/19
13:45
Options
Realogy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
03/25/19
03/25
13:45
03/25/19
13:45
General news
Euro$ interest rate futures are cracking higher »

Euro$ interest rate…

AAPL

Apple

$188.55

-2.56 (-1.34%)

, GS

Goldman Sachs

$188.87

0.3 (0.16%)

13:43
03/25/19
03/25
13:43
03/25/19
13:43
Hot Stocks
Apple partners with Goldman Sachs, Mastercard to launch Apple Card »

Apple (AAPL) announced…

AAPL

Apple

$188.55

-2.56 (-1.34%)

GS

Goldman Sachs

$188.87

0.3 (0.16%)

MA

MasterCard

$229.47

-1.3 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 15

    Apr

  • 03

    Jun

  • 25

    Jun

AAPL

Apple

$188.55

-2.56 (-1.34%)

13:43
03/25/19
03/25
13:43
03/25/19
13:43
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple aanounces Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

CCL

Carnival

$56.60

-0.13 (-0.23%)

, MKC

McCormick

$142.96

0.66 (0.46%)

13:42
03/25/19
03/25
13:42
03/25/19
13:42
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CCL

Carnival

$56.60

-0.13 (-0.23%)

MKC

McCormick

$142.96

0.66 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 26

    Mar

  • 27

    Mar

RHT

Red Hat

$181.76

0.13 (0.07%)

13:42
03/25/19
03/25
13:42
03/25/19
13:42
Earnings
Notable companies reporting after market close »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$188.87

-2.24 (-1.17%)

13:40
03/25/19
03/25
13:40
03/25/19
13:40
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple CEO Tim Cook says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

13:39
03/25/19
03/25
13:39
03/25/19
13:39
Conference/Events
Cantor Fitzgerald tech services analyst to hold analyst/industry conference call »

Tech Services Analyst…

AAPL

Apple

$188.31

-2.8 (-1.47%)

13:39
03/25/19
03/25
13:39
03/25/19
13:39
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple says Apple Card…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$188.39

-2.72 (-1.42%)

13:38
03/25/19
03/25
13:38
03/25/19
13:38
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple says physical card…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$188.78

-2.33 (-1.22%)

13:37
03/25/19
03/25
13:37
03/25/19
13:37
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple says Apple Card…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

OESX

Orion Energy

$0.91

0.017 (1.90%)

13:36
03/25/19
03/25
13:36
03/25/19
13:36
Hot Stocks
Orion CEO says focused on Enterprise grade LED lighting »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

AAPL

Apple

$188.96

-2.15 (-1.13%)

, MA

MasterCard

$230.00

-0.77 (-0.33%)

13:36
03/25/19
03/25
13:36
03/25/19
13:36
Hot Stocks
Breaking Hot Stocks news story on Apple, MasterCard »

Apple partered with…

AAPL

Apple

$188.96

-2.15 (-1.13%)

MA

MasterCard

$230.00

-0.77 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

  • 25

    Jun

EIGR

Eiger BioPharmaceuticals

$13.60

-0.31 (-2.23%)

13:35
03/25/19
03/25
13:35
03/25/19
13:35
Hot Stocks
Eiger announces Phase 2 PREVENT study met primary efficacy endpoint »

Eiger BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$189.34

-1.77 (-0.93%)

, GS

Goldman Sachs

$188.80

0.23 (0.12%)

13:35
03/25/19
03/25
13:35
03/25/19
13:35
Hot Stocks
Breaking Hot Stocks news story on Apple, Goldman Sachs »

Apple partnered with…

AAPL

Apple

$189.34

-1.77 (-0.93%)

GS

Goldman Sachs

$188.80

0.23 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 15

    Apr

  • 03

    Jun

AAPL

Apple

$189.25

-1.86 (-0.97%)

13:34
03/25/19
03/25
13:34
03/25/19
13:34
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple Card has no late…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.29

-1.82 (-0.95%)

13:33
03/25/19
03/25
13:33
03/25/19
13:33
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple says Daily Cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.33

-1.78 (-0.93%)

13:32
03/25/19
03/25
13:32
03/25/19
13:32
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple Card will give 2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.76

-1.35 (-0.71%)

13:31
03/25/19
03/25
13:31
03/25/19
13:31
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple Card has Daily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

EADSY

Airbus

$0.00

(0.00%)

13:30
03/25/19
03/25
13:30
03/25/19
13:30
Hot Stocks
Airbus signs agreement with China for 300 aircraft »

Airbus and China Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$36.81

0.3 (0.82%)

13:30
03/25/19
03/25
13:30
03/25/19
13:30
Options
7K GM May 34 - 38 put spreads sold $1.54 »

7K GM May 34 - 38 put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 30

    Apr

AAPL

Apple

$189.90

-1.21 (-0.63%)

13:29
03/25/19
03/25
13:29
03/25/19
13:29
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple Card in Wallet app,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.90

-1.21 (-0.63%)

13:28
03/25/19
03/25
13:28
03/25/19
13:28
Hot Stocks
Apple launches Apple News+ subscription service for $9.99 a month in U.S. »

Apple announced Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.55

-1.56 (-0.82%)

13:27
03/25/19
03/25
13:27
03/25/19
13:27
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple CEO Tim Cook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.50

-1.61 (-0.84%)

13:27
03/25/19
03/25
13:27
03/25/19
13:27
Hot Stocks
Apple adding Apple Pay Transit in Portland, Chicago, NYC later this year »

Apple Pay Transit allows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.